Evidence map›Paper›PMID 34440809›Full record

ArticleCells2021

High Glycolytic Activity Enhances Stem Cell Reprogramming of Fahd1-KO Mouse Embryonic Fibroblasts.

Ahmad Salti, Solmaz Etemad, Marta Suarez Cubero, Eva Albertini, Beata Kovacs-Szalka, Max Holzknecht, Elia Cappuccio, Maria Cavinato, Frank Edenhofer, Pidder Jansen Dürr

Open access · goldAbstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Ahmad SaltiInstitute of Molecular Biology and CMBI, Department of Genomics, Stem Cell Biology and Regenerative Medicine, University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0002-7678-0125
Solmaz EtemadInstitute for Biomedical Aging Research, University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0001-5789-1922
Marta Suarez CuberoInstitute of Molecular Biology and CMBI, Department of Genomics, Stem Cell Biology and Regenerative Medicine, University of Innsbruck, 6020 Innsbruck, Austria.
Eva AlbertiniInstitute for Biomedical Aging Research, University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0002-8167-5821
Beata Kovacs-SzalkaInstitute for Biomedical Aging Research, University of Innsbruck, 6020 Innsbruck, Austria.
Max HolzknechtInstitute for Biomedical Aging Research, University of Innsbruck, 6020 Innsbruck, Austria.
Elia CappuccioInstitute for Biomedical Aging Research, University of Innsbruck, 6020 Innsbruck, Austria.
Maria CavinatoInstitute for Biomedical Aging Research, University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0002-4891-9636
Frank EdenhoferInstitute of Molecular Biology and CMBI, Department of Genomics, Stem Cell Biology and Regenerative Medicine, University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0002-6489-714X
Pidder Jansen DürrInstitute for Biomedical Aging Research, University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0001-7771-3429
Universität Innsbruck · ATJohannes Kepler University of Linz · AT

Funding

Austrian Science Fund ZFP315820Austrian Science Fund FWF P 31582
6 · The paper itself

Abstract

Mitochondria play a key role in metabolic transitions involved in the reprogramming of somatic cells into induced pluripotent stem cells (iPSCs), but the underlying molecular mechanisms remain largely unexplored. To obtain new insight into the mechanisms of cellular reprogramming, we studied the role of FAH domain-containing protein 1 (FAHD1) in the reprogramming of murine embryonic fibroblasts (MEFs) into iPSCs and their subsequent differentiation into neuronal cells. MEFs from wild type (WT) and Fahd1-knock-out (KO) mice were reprogrammed into iPSCs and characterized for alterations in metabolic parameters and the expression of marker genes indicating mitochondrial biogenesis. Fahd1-KO MEFs showed a higher reprogramming efficiency accompanied by a significant increase in glycolytic activity as compared to WT. We also observed a strong increase of mitochondrial DNA copy number and expression of biogenesis marker genes in Fahd1-KO iPSCs relative to WT. Neuronal differentiation of iPSCs was accompanied by increased expression of mitochondrial biogenesis genes in both WT and Fahd1-KO neurons with higher expression in Fahd1-KO neurons. Together these observations establish a role of FAHD1 as a potential negative regulator of reprogramming and add additional insight into mechanisms by which FAHD1 modulates mitochondrial functions.

Indexed as

Cellular ReprogrammingAnimalsCell DifferentiationCell LineDNA, MitochondrialFibroblastsGlycolysisHydrolasesInduced Pluripotent Stem CellsMiceMice, Inbred C57BLMice, KnockoutMitochondriaNeuronsOxidative PhosphorylationDNA, MitochondrialHydrolasesFAHD1glycolytic activityiPSCsmitochondrianeuronal differentiationoxidative phosphorylationreprogramming

Identifiers

PMID34440809
PMCPMC8392800
OpenAlexW3187222274

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.